Petros Levounis, MD, MA
Reflecting sweeping changes in the understanding of gender and sexuality over the past decade, this session will provide an informative and affirming discussion of addiction treatment for clinicians working with patients of diverse gender and sexual identities. The session will focus on the re-emergence of crystal methamphetamine among gay men. Methamphetamine use has grown increasingly prevalent over the past decade, and fentanyl-contaminated methamphetamine has led to a significant increase in overdose deaths. Though no FDA-approved medications exist yet to treat methamphetamine use disorder, new research has demonstrated patient success with culturally sensitive, safe, and effective treatments.
This presentation was recorded at the 2022 Integrative Healthcare Symposium Annual Conference.